Greenlight Capital Buys DXC Technology Co, Sells Altice USA Inc, The Medicines Co, Dillard's Inc

Author's Avatar
Feb 14, 2020
Article's Main Image
Investment company Greenlight Capital (Current Portfolio) buys DXC Technology Co, sells Altice USA Inc, The Medicines Co, Dillard's Inc, Voya Financial Inc, Tempur Sealy International Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Greenlight Capital. As of 2019Q4, Greenlight Capital owns 18 stocks with a total value of $1.3 billion. These are the details of the buys and sells.

For the details of David Einhorn's stock buys and sells, go to https://www.gurufocus.com/guru/david+einhorn/current-portfolio/portfolio

These are the top 5 holdings of David Einhorn
  1. Green Brick Partners Inc (GRBK) - 24,118,668 shares, 20.55% of the total portfolio.
  2. General Motors Co (GM) - 6,154,702 shares, 16.71% of the total portfolio.
  3. AerCap Holdings NV (AER) - 3,200,769 shares, 14.60% of the total portfolio. Shares reduced by 8.1%
  4. Brighthouse Financial Inc (BHF) - 3,574,000 shares, 10.40% of the total portfolio.
  5. The Chemours Co (CC) - 6,810,743 shares, 9.14% of the total portfolio. Shares added by 5.05%
New Purchase: DXC Technology Co (DXC)

Greenlight Capital initiated holding in DXC Technology Co. The purchase prices were between $26.33 and $37.76, with an estimated average price of $32.83. The stock is now traded at around $30.82. The impact to a portfolio due to this purchase was 2.27%. The holding were 813,000 shares as of .

Sold Out: Dillard's Inc (DDS)

Greenlight Capital sold out a holding in Dillard's Inc. The sale prices were between $65.82 and $77.45, with an estimated average price of $70.97.

Sold Out: Voya Financial Inc (VOYA)

Greenlight Capital sold out a holding in Voya Financial Inc. The sale prices were between $50.67 and $61.75, with an estimated average price of $56.57.

Reduced: Altice USA Inc (ATUS)

Greenlight Capital reduced to a holding in Altice USA Inc by 32.31%. The sale prices were between $24.92 and $31.61, with an estimated average price of $27.58. The stock is now traded at around $28.71. The impact to a portfolio due to this sale was -2.13%. Greenlight Capital still held 2,157,740 shares as of .

Reduced: The Medicines Co (MDCO)

Greenlight Capital reduced to a holding in The Medicines Co by 68.58%. The sale prices were between $49.68 and $84.94, with an estimated average price of $67.5. The stock is now traded at around $84.90. The impact to a portfolio due to this sale was -1.8%. Greenlight Capital still held 229,900 shares as of .

Reduced: Tempur Sealy International Inc (TPX)

Greenlight Capital reduced to a holding in Tempur Sealy International Inc by 43.33%. The sale prices were between $73.26 and $90.95, with an estimated average price of $83.87. The stock is now traded at around $95.91. The impact to a portfolio due to this sale was -1.14%. Greenlight Capital still held 267,500 shares as of .

Reduced: Scientific Games Corp (SGMS)

Greenlight Capital reduced to a holding in Scientific Games Corp by 24.61%. The sale prices were between $19.52 and $31.58, with an estimated average price of $25.89. The stock is now traded at around $28.82. The impact to a portfolio due to this sale was -0.54%. Greenlight Capital still held 1,126,842 shares as of .



Here is the complete portfolio of David Einhorn. Also check out:

1. David Einhorn's Undervalued Stocks
2. David Einhorn's Top Growth Companies, and
3. David Einhorn's High Yield stocks
4. Stocks that David Einhorn keeps buying